In agreement, some studies have related these processes to low-grade systemic inflammation [31] and oxidative stress (caused by changes in metabolic processes) [32], which are present in patients with CKD and can be characterized by high levels of circulating inflammatory proteins and the presence of oxidative stress biomarkers, respectively [33]. This evidence concerns the gene PROS1 and chronic kidney disease.